Details

Autor(en) / Beteiligte

• Thompson, Elizabeth D.
• Roberts, Nicholas J.
• Wood, Laura D.
• Eshleman, James R.
• Goggins, Michael G.
• Kern, Scott E.
• Klein, Alison P.
• Hruban, Ralph H.

Titel

The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go

Ist Teil von

• Modern pathology, 2020-12, Vol.33 (12), p.2544-2563

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• The publication of the “Pan-Cancer Atlas” by the Pan-Cancer Analysis of Whole Genomes Consortium, a partnership formed by The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC), provides a wonderful opportunity to reflect on where we stand in our understanding of the genetics of pancreatic cancer, as well as on the opportunities to translate this understanding to patient care. From germline variants that predispose to the development of pancreatic cancer, to somatic mutations that are therapeutically targetable, genetics is now providing hope, where there once was no hope, for those diagnosed with pancreatic cancer.